$WTMA
Welsbach Technology Metals Acquisition Corp. Stock $wtma

$wtma Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000121390024099817 Filed on November 19, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q4
Revenue		$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$225.5K	$328.5K
YoY Change		-62.76%	-75.27%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$225.5K	$328.5K
YoY Change		-62.76%	-75.27%
Operating Profit		-$225.5K
YoY Change		-62.76%
Interest Expense		$180.5K	$313.6K
YoY Change		-64.45%	-52.49%
% of Operating Profit
Other Income/Expense, Net		$180.5K
YoY Change		-64.45%
Pretax Income		-$44.97K	-$14.94K
YoY Change		-53.94%	-97.77%
Income Tax		$35.73K	$0.00
% Of Pretax Income
Net Earnings		-$80.70K	-$14.94K
YoY Change		-149.12%	-98.12%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share		-$0.02	$0.00
COMMON SHARES
Basic Shares Outstanding	3.367M shares	3.367M shares	4.457M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.190K	$6.760K
YoY Change	-98.74%	-97.82%
Cash & Equivalents	$1.185K	$6.760K
Short-Term Investments
Other Short-Term Assets	$20.25K	$830.00
YoY Change	-51.92%	-96.68%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$21.44K	$7.593K
YoY Change	-84.32%	-97.73%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles		$5.000M
YoY Change		0.0%
Long-Term Investments	$12.23M	$23.77M
YoY Change	-69.13%	-70.16%
Other Assets	$0.00	$161.5K
YoY Change	-100.0%	-24.27%
Total Long-Term Assets	$12.23M	$23.93M
YoY Change	-69.29%	-70.03%
TOTAL ASSETS
Total Short-Term Assets	$21.44K	$7.593K
Total Long-Term Assets	$12.23M	$23.93M
Total Assets	$12.25M	$23.94M
YoY Change	-69.34%	-70.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.773M	$2.846M
YoY Change	-0.69%	56.5%
Accrued Expenses	$28.43K	$80.00K
YoY Change	-91.54%	-51.03%
Deferred Revenue
YoY Change
Short-Term Debt	$3.589M	$2.845M
YoY Change	29.08%	84.11%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.550M	$6.649M
YoY Change	-66.68%	69.88%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.705M	$2.705M
YoY Change	0.0%	0.0%
Total Long-Term Liabilities	$2.705M	$2.705M
YoY Change	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.550M	$6.649M
Total Long-Term Liabilities	$2.705M	$2.705M
Total Liabilities	$10.25M	$9.353M
YoY Change	-59.57%	41.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.13M	-$9.266M
YoY Change	12.75%	56.0%
Common Stock	$228.00	$228.00
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$10.13M	-$9.266M
YoY Change
Total Liabilities & Shareholders Equity	$12.25M	$23.94M
YoY Change	-69.34%	-70.15%

Cashflow Statement

Concept	2024 Q3	2023 Q4
OPERATING ACTIVITIES
Net Income	-$80.70K	-$14.94K
YoY Change	-149.12%	-98.12%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$361.5K	-$647.2K
YoY Change	3.2%	205.68%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$12.22M	$16.16M
YoY Change	-8065.96%	-3506.34%
Cash From Investing Activities	$12.22M	$16.16M
YoY Change	-8065.96%	-3506.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-12.03M	-15.65M
YoY Change	-1729.04%	-2125.23%
NET CHANGE
Cash From Operating Activities	-361.5K	-647.2K
Cash From Investing Activities	12.22M	16.16M
Cash From Financing Activities	-12.03M	-15.65M
Net Change In Cash	-169.4K	-139.5K
YoY Change	-172.18%	-260.93%
FREE CASH FLOW
Cash From Operating Activities	-$361.5K	-$647.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-1006702
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4422 N. Ravenswood Ave #1025
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60640
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41183
	dei	Entity Registrant Name EntityRegistrantName	Welsbach Technology Metals Acquisition Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address City Or Town EntityAddressCityOrTown	Chicago
	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
	dei	City Area Code CityAreaCode	+1 (251)
	dei	Local Phone Number LocalPhoneNumber	-280-1980
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3366765	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1185	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6760	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20250	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	833	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	21435	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	7593	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	161449	usd
CY2024Q3	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	12230126	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	23769229	usd
CY2024Q3	us-gaap	Assets Assets	12251561	usd
CY2023Q4	us-gaap	Assets Assets	23938271	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2772502	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2846126	usd
CY2024Q3	wtma	Franchise Tax Payable Current FranchiseTaxPayableCurrent	28427	usd
CY2023Q4	wtma	Franchise Tax Payable Current FranchiseTaxPayableCurrent	80000	usd
CY2024Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	70828	usd
CY2024Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	705718	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	583520	usd
CY2024Q3	wtma	Working Capital Loans Related Party Current WorkingCapitalLoansRelatedPartyCurrent	1292679	usd
CY2023Q4	wtma	Working Capital Loans Related Party Current WorkingCapitalLoansRelatedPartyCurrent	549100	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7550188	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6648780	usd
CY2024Q3	wtma	Deferred Underwriting Fee Payable Non Current DeferredUnderwritingFeePayableNonCurrent	2704690	usd
CY2023Q4	wtma	Deferred Underwriting Fee Payable Non Current DeferredUnderwritingFeePayableNonCurrent	2704690	usd
CY2024Q3	us-gaap	Liabilities Liabilities	10254878	usd
CY2023Q4	us-gaap	Liabilities Liabilities	9353470	usd
CY2024Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1082789	shares
CY2024Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	11.2
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2172851	shares
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.98
CY2024Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	12130098	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	23850678	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2283976	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2283976	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2283976	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2283976	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	228	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	228	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10133643	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9266105	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-10133415	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-9265877	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12251561	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23938271	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	215108	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	544383	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	757950	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1721711	usd
CY2024Q3	wtma	Franchise Tax FranchiseTax	10400	usd
CY2023Q3	wtma	Franchise Tax FranchiseTax	61141	usd
	wtma	Franchise Tax FranchiseTax	117212	usd
	wtma	Franchise Tax FranchiseTax	172771	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-225508	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-605524	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-875162	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1894482	usd
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	180541	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	507906	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	699861	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1855102	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	180541	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	507906	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	699861	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1855102	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-44967	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-97618	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-175301	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39380	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	35730	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-261911	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	70828	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-80697	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	164293	usd
	us-gaap	Net Income Loss NetIncomeLoss	-246129	usd
	us-gaap	Net Income Loss NetIncomeLoss	-39380	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-9265877	usd
CY2024Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	189223	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-70160	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-9525260	usd
CY2024Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	175577	usd
CY2024Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-122198	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-95272	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-9918307	usd
CY2024Q3	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	134411	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-80697	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-10133415	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5939636	usd
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	750670	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-230201	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-6920507	usd
CY2023Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	722985	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	26528	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-7616964	usd
CY2023Q3	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	951187	usd
CY2023Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-583520	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	164293	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-8987378	usd
	us-gaap	Net Income Loss NetIncomeLoss	-246129	usd
	us-gaap	Net Income Loss NetIncomeLoss	-39380	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	699861	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1855102	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	19417	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	17121	usd
	us-gaap	Increase Decrease In Due To Affiliates Current IncreaseDecreaseInDueToAffiliatesCurrent	90000	usd
	us-gaap	Increase Decrease In Due To Affiliates Current IncreaseDecreaseInDueToAffiliatesCurrent	58000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-73624	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	973107	usd
	wtma	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	-51573	usd
	wtma	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	172771	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	70828	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	7489	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-929776	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-700236	usd
	wtma	Payments For Cash Deposited To Trust Account PaymentsForCashDepositedToTrustAccount	750000	usd
	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	124166	usd
	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	124166	usd
	wtma	Proceeds From Trust Accounts In Connection With Redemption ProceedsFromTrustAccountsInConnectionWithRedemption	12219791	usd
	wtma	Proceeds From Trust Accounts In Connection With Redemption ProceedsFromTrustAccountsInConnectionWithRedemption	42636600	usd
	wtma	Proceeds From Trust Account To Pay Franchise And Income Taxes ProceedsFromTrustAccountToPayFranchiseAndIncomeTaxes	19173	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12238964	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	41886600	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	12219791	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	42636600	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1234934	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	743579	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11476212	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-41401666	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-167024	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-215302	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168209	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	523063	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1185	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	307761	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1185	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	94579	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	213182	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1185	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	307761	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12610	usd
	wtma	Franchise Taxes FranchiseTaxes	168785	usd
	wtma	Accretion For Redeemable Common Stock To Redemption Value AccretionForRedeemableCommonStockToRedemptionValue	499211	usd
	wtma	Accretion For Redeemable Common Stock To Redemption Value AccretionForRedeemableCommonStockToRedemptionValue	2424842	usd
	wtma	Excise Tax On Redemption Of Common Stock ExciseTaxOnRedemptionOfCommonStock	122198	usd
	wtma	Excise Tax On Redemption Of Common Stock ExciseTaxOnRedemptionOfCommonStock	583520	usd
	wtma	Due To Stockholder For Redemption Of Common Stock DueToStockholderForRedemptionOfCommonStock	15715387	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2021-05-27
	wtma	Underwriters Option Period UnderwritersOptionPeriod	P45D
CY2024Q3	wtma	Deferred Underwriting Fee Payable Non Current DeferredUnderwritingFeePayableNonCurrent	2704690	usd
	wtma	Investment Maturity Days InvestmentMaturityDays	P185D
CY2024Q3	us-gaap	Share Price SharePrice	10
CY2024Q3	us-gaap	Other Assets OtherAssets	5000001	usd
CY2024Q3	wtma	Percentage Of Public Share Sold In Initial Public Offering PercentageOfPublicShareSoldInInitialPublicOffering	0.20	pure
CY2024Q3	wtma	Percentage Of Obligation To Redeem Public Shares PercentageOfObligationToRedeemPublicShares	1	pure
	wtma	Dissolution Expenses DissolutionExpenses	100000	usd
CY2022Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	772769	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	772769	usd
CY2023Q1	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	42600000	usd
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1125000	shares
CY2024Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	6200000000	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.01	pure
	wtma	Percentage Of Excise Tax PercentageOfExciseTax	0.01	pure
	wtma	Percentage Of Additional Interest And Penalities PercentageOfAdditionalInterestAndPenalities	0.10	pure
	wtma	Percentage Of Underpayment Penalty PercentageOfUnderpaymentPenalty	0.05	pure
	wtma	Percentage Of Total Liability PercentageOfTotalLiability	0.25	pure
	wtma	Percentage Of Shares Redeemed PercentageOfSharesRedeemed	0.01	pure
	wtma	Percentage Of Excise Tax PercentageOfExciseTax	0.01	pure
CY2024Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	705718	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	583520	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1185	usd
CY2024Q3	wtma	Working Capital Deficit WorkingCapitalDeficit	7528753	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	wtma	Proceeds From Trust Accounts In Connection With Redemption ProceedsFromTrustAccountsInConnectionWithRedemption	12219791	usd
	wtma	Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes	19173	usd
CY2023	wtma	Cash Withdrawn From Trust Account CashWithdrawnFromTrustAccount	741013	usd
CY2023	wtma	Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes	579564	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	161449	usd
	wtma	Offering Costs Associated With The Ipo And Overallotment OfferingCostsAssociatedWithTheIPOAndOverallotment	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Offering Costs associated with the IPO and over-allotment</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Offering costs consist principally of legal, accounting, underwriting fees and other costs directly related to the IPO. Offering costs of the IPO amounted to $4,663,218, which was charged against additional paid-in capital and common stock subject to redemption upon the completion of the IPO. Subsequently, additional offering cost of $125,228 was incurred with the Over-allotment in January 2022 and was also charged against additional paid-in capital and common stock subject to redemption in January 2022.</p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Concentration of Credit Risk</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit. As of September 30, 2024, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.</p>
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.7946	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	2.683	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.404	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	7489	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	12610	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	7489	usd
CY2024Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1082789	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2172851	shares
	wtma	Limited Exception LimitedException	0.50	pure
	wtma	Number Of Trading Days NumberOfTradingDays	P20D
	wtma	Trading Day Period Commencing After Business Combination TradingDayPeriodCommencingAfterBusinessCombination	P30D
	wtma	Percentage Of Remaining Founder Shares PercentageOfRemainingFounderShares	0.50	pure
CY2023	us-gaap	Sponsor Fees SponsorFees	6000	usd
CY2023	wtma	Accrued Support Services AccruedSupportServices	26000	usd
CY2023Q3	wtma	Drawn From Promissory Note DrawnFromPromissoryNote	100	usd
	wtma	Working Capital Notes Exceed Amount WorkingCapitalNotesExceedAmount	1500000	usd
CY2024Q3	wtma	Working Capital Loans Related Party Current WorkingCapitalLoansRelatedPartyCurrent	1292679	usd
CY2023Q4	wtma	Working Capital Loans Related Party Current WorkingCapitalLoansRelatedPartyCurrent	549100	usd
CY2021Q4	us-gaap	Sponsor Fees SponsorFees	10000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	90000	usd
CY2023Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	30000	usd
	wtma	Underwriters Option Period UnderwritersOptionPeriod	P45D
CY2024Q3	wtma	Underwriting Fee Per Unit UnderwritingFeePerUnit	0.2
CY2024Q3	wtma	Sale Of Stock Underwriting Fees SaleOfStockUnderwritingFees	1545537	usd
	wtma	Additional Underwriting Payable Per Share AdditionalUnderwritingPayablePerShare	0.35
CY2024Q3	wtma	Deferred Underwriting Fee Payable Non Current DeferredUnderwritingFeePayableNonCurrent	2704690	usd
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100000	shares
CY2024Q2	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	10000000	usd
CY2024Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	6200000000	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2283976	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2283976	shares
CY2024Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1082789	shares
	wtma	Cash Withdrawn From Trust Account In Connection With Redemption CashWithdrawnFromTrustAccountInConnectionWithRedemption	70571778	usd
	wtma	Interest Earned On Trust Account To Pay Franchise And Income Taxes InterestEarnedOnTrustAccountToPayFranchiseAndIncomeTaxes	760186	usd
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent		usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
	wtma	Payments For Cash Deposited To Trust Account PaymentsForCashDepositedToTrustAccount		usd
	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties		usd
	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties		usd
	wtma	Proceeds From Trust Account To Pay Franchise And Income Taxes ProceedsFromTrustAccountToPayFranchiseAndIncomeTaxes		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	wtma	Franchise Taxes FranchiseTaxes		usd
	wtma	Due To Stockholder For Redemption Of Common Stock DueToStockholderForRedemptionOfCommonStock		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001866226

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001213900-24-099817-index-headers.html	Edgar Link	pending
0001213900-24-099817-index.html	Edgar Link	pending
0001213900-24-099817.txt	Edgar Link	pending
0001213900-24-099817-xbrl.zip	Edgar Link	pending
ea0221606-10q_welsbach.htm	Edgar Link	pending
ea022160601ex31-1_welsbach.htm	Edgar Link	pending
ea022160601ex31-2_welsbach.htm	Edgar Link	pending
ea022160601ex32-1_welsbach.htm	Edgar Link	pending
ea022160601ex32-2_welsbach.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wtma-20240930.xsd	Edgar Link	pending
wtma-20240930_cal.xml	Edgar Link	unprocessable
wtma-20240930_pre.xml	Edgar Link	unprocessable
wtma-20240930_lab.xml	Edgar Link	unprocessable
ea0221606-10q_welsbach_htm.xml	Edgar Link	completed
wtma-20240930_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WTMA
Welsbach Technology Metals Acquisition Corp. Stock $wtma

2024 Q4 Form 10-Q Financial Statement

#000121390024099817 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WTMA Welsbach Technology Metals Acquisition Corp. Stock $wtma

2024 Q4 Form 10-Q Financial Statement

#000121390024099817 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WTMA
Welsbach Technology Metals Acquisition Corp. Stock $wtma